232 related articles for article (PubMed ID: 37822706)
1. Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays.
Bouck EG; Grinsztejn E; Mcnamara M; Stavrou EX; Wolberg AS
Res Pract Thromb Haemost; 2023 Aug; 7(6):102197. PubMed ID: 37822706
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk associated with gender-affirming hormone therapy.
Mullins TLK; Mullins ES
J Thromb Haemost; 2024 May; ():. PubMed ID: 38795871
[TBL] [Abstract][Full Text] [Related]
3. Effects of Gender-Affirming Hormones on Lipid, Metabolic, and Cardiac Surrogate Blood Markers in Transgender Persons.
Defreyne J; Van de Bruaene LDL; Rietzschel E; Van Schuylenbergh J; T'Sjoen GGR
Clin Chem; 2019 Jan; 65(1):119-134. PubMed ID: 30602477
[TBL] [Abstract][Full Text] [Related]
4. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
5. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
6. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults.
Connelly PJ; Marie Freel E; Perry C; Ewan J; Touyz RM; Currie G; Delles C
Hypertension; 2019 Dec; 74(6):1266-1274. PubMed ID: 31656099
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Gender-Affirming Hormone Therapy and Cognitive Functioning in Older Transgender Women Compared With Cisgender Women and Men.
van Heesewijk JO; Dreijerink KMA; Wiepjes CM; Kok AAL; van Schoor NM; Huisman M; den Heijer M; Kreukels BPC
J Sex Med; 2021 Aug; 18(8):1434-1443. PubMed ID: 34247950
[TBL] [Abstract][Full Text] [Related]
8. Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis.
Turino Miranda K; Kalenga CZ; Saad N; Dumanski SM; Collister D; Rytz CL; Lorenzetti DL; Chang DH; McClurg C; Sola DY; Ahmed SB
Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H861-H868. PubMed ID: 36053748
[TBL] [Abstract][Full Text] [Related]
9. The Desire and Status of Gender-Affirming Hormone Therapy and Surgery in Transgender Men and Women in China: A National Population Study.
Liu Y; Xin Y; Qi J; Wang H; Hong T; Yang X; Li B; Chang X; Knudson G; Zhao Z; Pan B
J Sex Med; 2020 Nov; 17(11):2291-2298. PubMed ID: 32868262
[TBL] [Abstract][Full Text] [Related]
10. Providing Care for Transgender Persons With Kidney Disease: A Narrative Review.
Collister D; Saad N; Christie E; Ahmed S
Can J Kidney Health Dis; 2021; 8():2054358120985379. PubMed ID: 33552529
[TBL] [Abstract][Full Text] [Related]
11. Position statement on the hormonal management of adult transgender and gender diverse individuals.
Cheung AS; Wynne K; Erasmus J; Murray S; Zajac JD
Med J Aust; 2019 Aug; 211(3):127-133. PubMed ID: 31271465
[TBL] [Abstract][Full Text] [Related]
12. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
13. Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals.
Moustakli E; Tsonis O
Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138197
[TBL] [Abstract][Full Text] [Related]
14. Masculinizing hormone therapy effect on breast tissue: Changes in estrogen and androgen receptors in transgender female-to-male mastectomies.
Chaum M; Grossi S; Chen J; Hu V; Ray E; Giuliano A; Bose S
Breast; 2023 Dec; 72():103596. PubMed ID: 37951051
[TBL] [Abstract][Full Text] [Related]
15. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.
Krakowsky Y; Potter E; Hallarn J; Monari B; Wilcox H; Bauer G; Ravel J; Prodger JL
Front Cell Infect Microbiol; 2021; 11():769950. PubMed ID: 35127550
[TBL] [Abstract][Full Text] [Related]
17. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
Humble RM; Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2022 Sep; 7(5):1131-1144. PubMed ID: 35584132
[TBL] [Abstract][Full Text] [Related]
18. Affirming Hormone Treatment for a Transgender Adolescent After a Venous Thromboembolic Event.
Penney SW; Jung JH; Ballantyne AJ; Parekh DS; Klein DA; Viola SA
J Pediatr Hematol Oncol; 2022 Jul; 44(5):e892-e895. PubMed ID: 35293883
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis Risk in Transgender Adolescents Receiving Gender-Affirming Hormone Therapy.
Mullins ES; Geer R; Metcalf M; Piccola J; Lane A; Conard LAE; Mullins TLK
Pediatrics; 2021 Apr; 147(4):. PubMed ID: 33753543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
